When the Illini opened their season against Jackson State, a young forward named Jason Jakstys stepped onto the court and immediately made his presence felt, pulling down nine rebounds in just 12 minutes.
In only 10 minutes of action against Florida Gulf Coast, he posted a career‑high four points, shooting 4‑for‑5 from the field and 4‑for‑6 from the free‑throw line, a performance that hinted at a deeper role.
Jakstys went on to appear in eight more games, averaging 1.3 points, 1.9 rebounds and 0.4 blocks per contest, and he managed to score in five of those outings, including late contributions in wins over Missouri and Rutgers.
His most notable moments came against Texas Tech and Maryland, where he logged first‑half minutes and contributed a block in four of the nine appearances, underscoring a defensive spark.
The momentum was abruptly halted when doctors diagnosed him with thoracic outlet syndrome, a condition that compresses blood vessels near the shoulder, leading to a clot that forced him to miss the final 19 games of the 2025‑26 season.
Kyle Tausk, the Illini Inquirer analyst, broke down how the clot not only ended Jakstys’s campaign but also raised questions about the long‑term development of a player who had shown promise despite limited minutes.
Looking Ahead
While the blood clot cast a shadow over his sophomore year, the coaching staff remains optimistic that proper medical treatment and rehabilitation could restore Jakstys to full health, positioning him as a potential contributor in the next season’s rotation.
If he can stay healthy, the forward’s ability to crash the boards and protect the rim could become a valuable asset for a program looking to rebuild around youthful talent.